Jefferies Upgrades AveXis To Buy Following Positive AVXS-101 Data, Doc Feedback

By: via Benzinga
The updated AVXS-101 data released by AveXis Inc (NASDAQ: AVXS) suggests that the FDA may allow for a single-arm pivotal trial in SMA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.